Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Enzyme-Loaded Magnetic Nanoparticles Suitable for Therapeutic and Industrial Applications

By LabMedica International staff writers
Posted on 25 Apr 2016
Members of a novel class of nano-sized transport vessels are composed of only two biocompatible components: an enzyme and magnetite nanoparticles.

Magnetically controlled enzymatic nanoparticles have received much attention for both therapeutic and industrial applications. More...
Such materials usually comprise at least four components: the enzyme, magnetic nanoparticles, stabilizing components, and an organic or inorganic (or hybrid) matrix as a carrier. However, such combinations can affect the magnetic response and/or the enzymatic activity, and also face regulatory restrictions that prevent them from being used for intravenous administration.

To overcome these difficulties, investigators at ITMO University (St. Petersburg, Russia) and their colleagues at the Hebrew University of Jerusalem (Israel), and Cyril and Methodius University (Skopje, Macedonia) developed a new class of magnetically controlled nanoparticles made from enzymes that have been entrapped directly within magnetite particles.

These particles were made by adding enzymes directly to a magnetite hydrosol mixture. Magnetite particles surrounded the enzymes, and after drying, formed a firm porous structure from which the enzyme could not escape.

The investigators reported in the March 16, 2016, online edition of the journal Chemistry of Materials that they had used the direct entrapment approach to create a series of magnetic biocomposites with enzymes of therapeutic and industrial interest including carbonic anhydrase, ovalbumin, horseradish peroxidase, acid phosphatase, proteinase, and xylanase.

The activity of the entrapped enzymes was studied at different temperatures and concentrations, and it was found that they showed remarkable thermal stabilization induced by the magnetite matrix. For example, entrapped carbonic anhydrase catalyzed the decomposition of p-nitrophenylacetate at a temperature of 90 degrees Celsius, while the free enzyme completely lost activity and denaturized at 70 degrees Celsius.

"The nanocomposite is absolutely biocompatible and harmless for injection into the human body," said Dr. Andrey Drozdov, a research associate in the international laboratory of solution chemistry of advanced materials and technologies at ITMO University. "Separately, both magnetite and therapeutic enzymes have medical approval for intravenous injection. Therefore, to approve their joint use should not be difficult. The body already knows what to do with these substances and how to incorporate them into the process of metabolism. Using a magnetic field, the particles can be condensed on blood clots; moreover, such systems will work for quite a long time until the enzyme is completely oxidized."

Related Links:
ITMO University
Hebrew University of Jerusalem
Cyril and Methodius University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.